Physician profile
Eric J Gandras
NPI 1851419717
$132,712.77
in general payments reported to CMS, 2019-2025
4 companies · $21K in 2025
The $21K reported for 2025 was more than what 93% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $17K · 2021: $20K · 2022: $26K · 2023: $18K · 2024: $15K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $37K · Consulting Fee: $14K · Travel and Lodging: $1,577 · Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $37,323.63 |
| Consulting Fee | $14,151.38 |
| Travel and Lodging | $1,576.56 |
| Food and Beverage | $659.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $59,237.45 | 2021-2025 | Arrow |
| Vascular Solutions, INC. | $47,065.98 | 2019-2021 | |
| Instylla, INC. | $26,387.39 | 2021-2025 | Instylla Microcatheter, Instylla Delivery Kit |
| Depuy Synthes Sales INC. | $21.95 | 2024 | Trufill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Gandras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.